Comments on: Alfacell Corporation Granted U.S. Orphan Drug Designation For ONCONASE(R) For Treatment Of Malignant Mesothelioma

Comments on: Alfacell Corporation Granted U.S. Orphan Drug Designation For ONCONASE(R) For Treatment Of Malignant Mesothelioma http://www.lungcancerscreen.com/alfacell-corporation-granted-us-orphan-drug-designation-for-onconaser-for-treatment-of-malignant-mesothelioma/ Tue, 06 Jan 2009 01:59:09 +0000 http://wordpress.org/?v=1.5.2